VANGUARD GROUP INC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 245 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$249,222,000
-42.7%
1,442,171
-61.9%
0.02%
-45.2%
Q4 2014$434,969,000
-23.7%
3,784,309
+3.7%
0.03%
-29.5%
Q3 2014$570,079,000
+18.2%
3,648,738
-6.7%
0.04%
+15.8%
Q2 2014$482,342,000
+13.0%
3,910,354
-5.1%
0.04%
+5.6%
Q1 2014$426,933,000
+32.6%
4,120,577
+15.1%
0.04%
+28.6%
Q4 2013$322,052,000
+37.8%
3,580,743
+2.5%
0.03%
+21.7%
Q3 2013$233,676,000
+1.1%
3,493,966
-0.0%
0.02%
-4.2%
Q2 2013$231,228,0003,495,5010.02%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders